Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research.

Saved in:
Bibliographic Details
Title: Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research.
Authors: Smith EE; University of Calgary, Canada. Electronic address: eesmith@ucalgary.ca., Phillips NA; Concordia University, Canada., Feldman HH; Alzheimer's Disease Cooperative Study, Department of Neurosciences, University of California, San Diego, United States., Borrie M; Western University, Canada., Ganesh A; University of Calgary, Canada., Henri-Bhargava A; University of British Columbia, University of Victoria, Island Health, Canada., Desmarais P; Centre Hospitalier de l'Université de Montréal, Canada., Frank A; Bruyère Health Research Institute and University of Ottawa, Canada., Badhwar A; Centre de Recherche de l'Institut Universitaire de Gériatrie de Montréal, Université de Montreal, Canada., Barlow L; University of British Columbia, Canada., Bartha R; Western University, Canada., Best S; Western University, Canada., Bethell J; KITE Research Institute, Toronto Rehabilitation Institute - University Health Network, University of Toronto, Canada., Bhangu J; Western University, Canada., Black SE; Sunnybrook Research Institute, Canada., Bocti C; Université de Sherbrooke, Canada., Bronskill SE; Institute for Clinical Evaluative Sciences (ICES), Canada., Burhan AM; Ontario Shores Centre and University of Toronto, Canada., Calon F; Université Laval (Faculté de pharmacie), Canada., Camicioli R; University of Alberta, Canada., Campbell B; University of Manitoba, Canada., Collins DL; McGill University, Canada., Dadar M; McGill University, Canada., DeMarco ML; Providence Health Care, University of British Columbia, Canada., Ducharme S; McGill University - Douglas Institute, Canada., Duchesne S; Laval University, Canada., Einstein G; University of Toronto, Canada., Fisk JD; Dalhousie University, Canada., Gawryluk JR; University of Victoria, Canada., Grossman L; Person with lived experience, Canada., Ismail Z; University of Calgary, Canada., Itzhak I; Lady Davis Institute for Medical Research, Canada., Joshi M; University of Calgary, Canada., Harrison A; Person with lived experience, Canada., Kröger E; Université Laval, Canada., Kumar S; University of Toronto, Canada., Laforce R; Laval University, Canada., Lanctot KL; Sunnybrook Health Sciences Centre, Canada., Lau M; Person with lived experience, Canada., Lee L; McMaster University, Canada., Masellis M; Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Canada., Massoud F; Centre Hospitalier Charles LeMoyne / University of Sherbrooke, Canada., Mitchell SB; University of Toronto, Canada., Montero-Odasso M; Department of Medicine and Epidemiology and Biostatistics, Western University, Canada., Myers Barnett K; Person with lived experience, Canada., Nygaard HB; University of British Columbia, Canada., Pasternak SH; Western University, Parkwood Institute, Canada., Peters J; Person with lived experience, Canada., Rajah MN; Toronto Metropolitan University, Canada., Robillard JM; University of British Columbia, Canada., Rockwood K; Dalhousie University, Canada., Rosa-Neto P; McGill University, Canada., Seitz DP; University of Calgary, Canada., Soucy JP; McGill University, Canada., Trenaman SC; Dalhousie University and Nova Scotia Health, Canada., Wellington CL; Department of Pathology and Laboratory Medicine, University of British Columbia, Canada., Zadem A; Université de Sherbrooke, Canada., Chertkow H; Rotman Research Institute, Baycrest Centre, Canada.
Corporate Authors: Canadian Consortium on Neurodegeneration in Aging Investigators
Source: The journal of prevention of Alzheimer's disease [J Prev Alzheimers Dis] 2025 Mar; Vol. 12 (3), pp. 100068. Date of Electronic Publication: 2025 Jan 31.
Publication Type: Journal Article; Review
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101638820 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2426-0266 (Electronic) Linking ISSN: 22745807 NLM ISO Abbreviation: J Prev Alzheimers Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2426-0266
DOI:10.1016/j.tjpad.2025.100068